ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — Cash Flow Quality Index
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Cash Flow Quality Index of 1.41x as of June 2024. Operating cash flow of €6.22 Billion exceeds net income of €4.40 Billion, indicating high earnings quality where cash backs reported profits. Explore LDZU operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ASPEN PHAR.UN.ADR /1 O.N. Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for ASPEN PHAR.UN.ADR /1 O.N. across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see LDZU cash flow conversion.
Annual Cash Flow Quality Index for ASPEN PHAR.UN.ADR /1 O.N. (2022–2024)
Year-by-year earnings quality comparison for ASPEN PHAR.UN.ADR /1 O.N..
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.41x | €6.22 Billion | €4.40 Billion | ▲ +33.9% |
| 2023 | 1.06x | €5.52 Billion | €5.23 Billion | ▲ +27.5% |
| 2022 | 0.83x | €5.37 Billion | €6.49 Billion | — |